Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
ACB · Nasdaq · United States · Medicinal Chemicals & Botanical Products
In shortAURORA CANNABIS INC is profitable, generates cash and holds more cash than debt, with revenue growing (+27.3% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 1.4% | 21/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 0.5% | 22/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 0.3% | 1/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 0.6% | 4/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 4.31× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.07× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 0.59× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -19.04 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 4.7% | 39/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 10.06× | 100/100 |
| Years with positive free cash flow (last 5) | 1 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 5 | 20/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 16.5% | 50/100 |
| Operating margin volatility | 62.1% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 6.0% | 50/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
CAD millions; negative values in parentheses.
| Fiscal year | FY20 | FY21 | FY22 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 313 | 289 | 252 | 270 | 343 |
| Gross profit | (20) | (22) | 21 | 132 | 188 |
| Research & development | 26 | 11 | 10 | 3.6 | 3.7 |
| Selling, general & admin | – | 175 | 175 | 144 | – |
| Operating income | (466) | (283) | (231) | (45) | 4.9 |
| Interest expense | 76 | 66 | 72 | 14 | 8.4 |
| Pre-tax income | (3,340) | (700) | (1,720) | (58) | 20 |
| Income tax | (82) | (6.3) | (2.1) | (0.6) | 4.6 |
| Net income | (3,283) | (692) | (1,718) | (69) | 1.6 |
| Diluted EPS | −C$33.93 | −C$4.10 | −C$7.99 | −C$1.52 | C$0.04 |
| Diluted shares (millions) | 97 | 169 | 215 | 43 | 56 |
2 older years available with the 10-year history. Essential plan, from €8.25/month →
−19.04 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
7/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Mar 31, 2026 · Data updated Jun 18, 2025